Mirae Asset Global Investments
NGM

Mirae Asset Global Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Mirae Asset Global Investments’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,169
Closed -$80.9K – 2682
2024
Q1 		$80.9K Buy
+21,169
New +$31.4K ﹤0.01% 2392
2023
Q3 		– Sell
-23,031
Closed -$59.7K – 2656
2023
Q2 		$59.7K Sell
23,031
-162
-0.7% -$578 ﹤0.01% 2582
2023
Q1 		$94.6K Sell
23,193
-44
-0.2% -$203 ﹤0.01% 2455
2022
Q4 		$117K Buy
23,237
+62
+0.3% +$389 ﹤0.01% 2431
2022
Q3 		$303K Buy
23,175
+12,201
+111% +$185K ﹤0.01% 2156
2022
Q2 		$141K Buy
+10,974
New +$152K ﹤0.01% 2253

Mirae Asset Global Investments's NGM Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 21,169 shares — an estimated $80.9K sold.

Mirae Asset Global Investments first reported a position in NGM in Q2 2022 and held it in 6 quarters. The position peaked at $303K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 21,169 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $80.9K.
  • Mirae Asset Global Investments first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Mirae Asset Global Investments's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $303K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.